The telehealth could be positively used for
the cure, treatment and effective care of the chronic diseases namely diabetes
and cancer. Chronic syndrome decrease an individual’s quality of life,
particularly if left undiagnosed and unprocessed. The telehealth can be
utilized to address the growing requirement for healthcare services for cancer,
diabetes and several other diseases in underdeveloped countries. Thus, the wide
prevalence of such syndromes is predicted to fuel the market growth during the
review period.
Furthermore, the telehealth market is
positively observing a wider acceptance rate due to an increment geriatric
populace, commonness of the chronic syndromes, and greatest government
expenditure on the healthcare. The telehealth has made it possible to deliver
the good healthcare services by the bridging the gap among the doctors and
patients.
According to the report analysis, ‘Global
Telehealth Market (2018-2023)’ states that in the telehealth market,
there are numerous key players which positively functioning for leading the
fastest market growth and registering the high value of market share around the
globe in the coming years more enormously while developing the telehealth
services, decreasing the price of the services, delivering better consumer
satisfaction and spreading the awareness around the globe related to the
applications of the telehealth services includes McKesson Corporation,
Medtronic Inc., Cisco Systems, GE Healthcare, Allscripts Healthcare, Siemens
Healthineers, LifeWatch AG, Philips Healthcare, Honeywell, Cerner Corporation
and several others.
Additionally, the wide acceptance of the
teledermatology is the uppermost among the application sectors, owing to the
extraordinary cost of specialty healthcare. This sector involves the dermatology
and makes available unconventional imaging technologies. Close on its heels are
teleradiology (25%) and telecardiology (24%). The Telecardiology is fostered by
the higher pervasiveness of cardiac ailments across the globe, and specific
heart situations such as the cardiac arrhythmia which need the constant
monitoring over a long duration. The Cancer patients demand the regular
check-ups, which may not be possible for patients who sojourn far from
hospitals. Teleradiology is an advantage for these patients, permitting them to
chief the healthy lives.
The Remote patient monitoring (RPM) engaged a
foremost market share of 63% in 2017, being the most predominant telehealth
technology. Current regulations in regions like the United States (U.S.), Canada,
and the United Kingdom (U.K.), mandate the imposition of fines on readmission
of patients within 30 days of discharge. These guidelines, along with
increasing healthcare costs, are the momentous drivers of RPM acceptance.
Mobile health (mHealth), having controlled a market share of 22% in the same
year, presents a lot of promise in the great allocation of the medical
information to both patients and medical physicians. Video telemedicine
registered for a share of 15% in 2017.
In addition, based on the region, the North
America region has exhibited the foremost acceptance of the telehealth
technologies and engaged approximately 49% of the global market in 2017. The
country has rigorous healthcare regulations, along with a wide incidence of
chronic diseases and vertical healthcare expenditures for employers, all of
which resulted in the broader application of telehealth. The significant
government investments in improving the telehealth infrastructure have led to
the growth of the market in Europe region. In the present ear, the region
registers for a 33% market share. Asia-Pacific, Latin America, and the Middle
East and Africa are embryonic markets which are predicted to exhibit huge
growth in the future.
Therefore, in the coming years, it is
anticipated that the market of telehealth will increase around the globe over
the forecast period.
For more information, click on the
link below:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing &
Communications
+91
9015378249